Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?

Journal of Clinical Investigation - United States
doi 10.1172/jci67589
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Green Tea and Liver Cancer

HepatoBiliary Surgery and Nutrition
2017English

Phosphodiesterase-5 Inhibitors and Colorectal Cancer: A New Frontier for Prevention?

Gastroenterology
HepatologyGastroenterology
2019English

Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy

Frontiers in Pharmacology
Pharmacology
2020English

Green Tea and Stomach Cancer -- A Short Review of Prospective Studies

Journal of Epidemiology
MedicineEpidemiology
2005English

Zaprinast, a Phosphodiesterase 5 Inhibitor, Overcomes Sexual Dysfunction Produced by Fluoxetine, a Selective Serotonin Reuptake Inhibitor in Hamsters

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2003English

Green Tea Polyphenols: Biology and Therapeutic Implications in Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2007English

Epigenetic Effects of Green Tea Polyphenols in Cancer

Epigenomics
Cancer ResearchGenetics
2013English

A Phosphodiesterase 5 Inhibitor, Tadalafil, Suppresses Stromal Predominance and Inflammation in a Rat Model of Nonbacterial Prostatitis

BMC Urology
MedicineReproductive MedicineUrology
2019English

Green Tea Consumption and Lung Cancer Risk: The Ohsaki Study

British Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy